A first-of-its-kind study led by Kerri Winters-Stone, Ph.D., tests approaches for fall prevention after chemotherapy treatment in postmenopausal women; she says, “We know exercising has an important role across the entire cancer continuum. Our goal was to dig deeper in this promising area for cancer survivors focused on their long-term health after treatment ends.”

OHSU School of Nursing researchers are partnering with 20 rural Oregon libraries -- including those in Scappoose, Nyssa and Dallas -- for an NIH-funded study evaluating whether library-organized community walking groups can improve rural health. Jim Winkle, M.P.H., says the study seeks to find “the key ingredient to sustainably implementing group walking programs in a rural community.”

Eneida Nemecek, M.D., is leading a new effort to increase participation in cancer clinical trials in the Latino communities by incorporating new strategies such as a Spanish-speaking patient navigator. She says: “One of the obstacles that Latino patients face when they enter the medical system is a communication barrier, and we want that [patient navigator] person to be almost a community link.”

At the European Association of Urology conference, researchers discuss progress in exploring the utility of an existing urine test for bladder cancer called UroAmp, which was developed by an OHSU spinout company.

The Miami Herald cites an article co-written by Jennifer H. Huang, M.D., that describes how research has shown most cases of post-vaccination heart inflammation, or myocarditis, have been mild and respond well to treatment, and how the overall myocarditis risk is significantly higher after COVID-19 infection.

Maria Rodriguez, M.D., and Alison Edelman, M.D., joined U.S. Sen. Ron Wyden and Oregon Attorney General Ellen Rosenblum in defending access to the abortion medications mifepristone and misoprostol. Rodriguez says: “We do not need judges, lawyers and politicians practicing medicine without a license in Texas or anywhere else in our country.”

A story about the Drug Enforcement Administration's new proposal that patients with substance use disorder who receive buprenorphine via telehealth see a professional in person every 30 days quotes Ximena Levander, M.D., as saying: “Where’s the evidence behind this 30-day requirement? There’s no evidence. It feels very arbitrary to say within 30 days come in. It’s really hard for a lot of people.”

Maria Rodriguez, M.D., and Alison Edelman, M.D., joined U.S. Sen. Ron Wyden and Oregon Attorney General Ellen Rosenblum in defending access to the abortion medications mifepristone and misoprostol. Rodriguez says: “We do not need judges, lawyers and politicians practicing medicine without a license in Texas or anywhere else in our country.”

Coverage of a proposed Oregon ban on flavored tobacco quotes James Bishara, M.D., who discusses the severe health risks of tobacco and addictive nature of flavored products among children and urges Oregonians to support harm-reduction measures.

Le Monde (France) profiles Charles Blanke, M.D., and his expertise in medically assisted dying in Oregon.